Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors.

Saved in:

Bibliographic Details
Title:	Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors.
Authors:	Saif, M.¹ wsaif@tuftsmedicalcenter.org, Erlichman, C.², Dragovich, T.³, Mendelson, D.⁴ dmendelson@azpoh.com, Toft, D.⁵, Burrows, F., Storgard, C., Hoff, D.⁶
Source:	Cancer Chemotherapy & Pharmacology. May2013, Vol. 71 Issue 5, p1345-1355. 11p.
Database:	Academic Search Ultimate

Description
ISSN:	03445704
DOI:	10.1007/s00280-013-2134-9